Netscientific Share Discussion Threads

[blakieboy7] 18/4/2024 09:31

Are you able to share the link loaf?

[loafofbread] 18/4/2024 09:21

Very bullish EMV First qtr newsletter just out.

Well worth a read.

[loafofbread] 17/4/2024 10:08

Decent sized buy delayed by an hour so should move up on the next one.

[loafofbread] 16/4/2024 23:20

Still can't quite believe we have only gained 1p on that news.

If they are going to sell the lot this summer for £10M in cash? then I hope they put a share buy back into the mix post results.

About time they started narrowing the discount of the 60p share price to the £2.00 asset value.

[blakieboy7] 15/4/2024 19:18

More like manure than panmure!!

[blakieboy7] 15/4/2024 11:08

Now would be a good time for Simon Thompson to write an article

[blakieboy7] 15/4/2024 08:58

Agreed. It's a nonsense

[kingston78] 15/4/2024 08:43

Until and unless there is a total exit crystallising the value of a portfolio company in cash the market will not appreciate it.

[blakieboy7] 15/4/2024 08:06

wtf does the share price not move on this RNS? It spells it out in black and white

[loafofbread] 15/4/2024 08:05

NAV is now well over £2.00 a share.

Madness!

[wapper] 15/4/2024 07:26

RNS .Time for a rerate here.

[blakieboy7] 11/4/2024 17:23

It seems like it's trapped in this low range

[kingston78] 06/4/2024 11:10

I am sure that there will be a significant announcement of divestment this year, realising a substantial gain for the company.

[loafofbread] 05/4/2024 13:23

Ventive 11%, EMV 25%

From Pipehawk half year 27/03/2024. They are one of the production partners for the new heat pump.

Recruitment has been a challenge as we have increased our staff levels to support the pending build profile of the contract manufacturing solutions. Inflation and cost of living increases have resulted in increased salary demands across the business. We have seen an increase of staff from 55 to 75 with more resource being required to support the contract manufacturing aspect of the business for both Caudwell Marine and Ventive, as well as considerations for Fast MDX, moving in to the latter stages of 2024. Commencement of contract manufacturing has suffered delays for the above reasons, but is moving ever closer. Caudwell is targeting start of production in July this year which will generate additional revenue towards the latter stages of 2024. In addition, Ventive has production targets on a similar timeframe.

[loafofbread] 05/4/2024 09:18

QBot 15%, EMV 32%

USA and Europe.

Q-Bot, the UK construction tech company that uses robotics and AI to insulate people’s homes, has strengthened its Board with the appointment of a new Executive Chair and a second Investment Director.
Victor Vadaneaux has been appointed Executive Chair of Q-Bot. Victor has worked within B2B services, the engineering industry and the healthcare sector, and has extensive business and private equity experience of the UK, EU and US markets, including several successful exits.
Malcolm Groat has been appointed an Investment Director of Q-Bot, to work alongside Dr Ilian Iliev, the company’s existing Investment Director. Malcolm has more than 25 years of experience as a Chair, NED, CFO, and CEO in the public and private markets.
These senior board appointments significantly enhance Q-Bot’s capabilities and take place at an exciting time for the company and the construction industry. Using AI and robotics, Q-Bot’s insulation is deployed beneath suspended timber floors or to the underside of suspended concrete floors. In the UK alone, Q-Bot’s high performance retrofit insulation can help insulate the 8 to 12 million homes that have suspended floors and which are hard to treat using traditional forms of insulation. In the UK, Q-Bot’s customers include social housing landlords, energy companies and private homeowners. Internationally, the company has identified a further multi-billion market for robotics-based retrofit of insulation to residential homes in North America and North West Europe.

Victor and Malcolm will help Q-Bot to scale its robotics-as-a-service sales in the UK and expand its digital retrofit service. As its next phase of growth, Q-Bot is set to launch in the US and scale in the EU through strategic partnerships.

Their appointments have been facilitated by EMV Capital, a key investor in Q-Bot, and the company continues to draw on the value creation services provided by EMV Capital.

[loafofbread] 05/4/2024 09:12

Have now launched SageTech Veterinary with a massive partnership.


At SageTech Veterinary, we are committed to eliminating waste, pollution and unnecessary environmental harm caused by volatile anaesthetic agents.

Our mission is to provide veterinary clinics with a safe, sustainable and easy to use solution for the capture, recovery and recycling of these agents, to lower their carbon footprint, and help to protect the planet for future generations.

SageTech Veterinary - Leading Sustainable Anaesthesia.

Find out more at www.sagetechveterinary.com

We are delighted to share our portfolio company SageTech Medical, the sustainable anaesthesia provider, has announced a partnership with Mars Veterinary Health and its UK veterinary clinic group Linnaeus.

A veterinary-industry first, Mars Veterinary Health’s one-year pilot will start with 10 Linnaeus primary care and referral veterinary practices in the UK with the aim of reducing anaesthesia-related carbon emissions resulting from release or disposal of these agents and determining the efficiency of capture in its clinics, ultimately supporting its goal of reducing climate-change impacts.

[loafofbread] 05/4/2024 09:08

SageTech on a roll. We hold 5.5%, EMV 32%.

Recently SageTech Medical delivered 10 SID-Dock waste volatile anaesthetic gas capture machines to Cromwell Hospital.


Another successful delivery and installation for SageTech Medical!

We are pleased to announce that last week we installed our SID-Dock waste volatile anaesthetic gas capture machine at Benenden Hospital!

Benenden are helping to lead the way in delivering sustainable anaesthesia and are the first independent private hospital to adopt our technology!

Our SID-Dock waste volatile anaesthetic gas capture machine was recently installed at Castle Hill Hospital in Hull!

Our SID-Dock waste volatile anaesthetic gas capture machine was recently installed at Crosshouse Hospital in Scotland!

[loafofbread] 30/3/2024 09:34

March Portfolio & Investment News

As we approach the end of an eventful Q1, the EMV Capital and NetScientific PLC Group is pleased to share the latest highlights across its deep tech and life sciences portfolio:

➡ Q-Bot Ltd has strengthened its Board with the appointment of Malcolm Groat as its second Investment Director, and a new Executive Chair to be announced shortly.
➡ ProAxsis has appointed EMV Capital and an external adviser to explore options for a potential sale of the company to a new strategic owner to scale the business to its full potential.
➡ SageTech Medical SID-Dock waste volatile anaesthetic gas capture machine was recently installed at NHS Ayrshire & Arran University Hospital Crosshouse and Hull University Teaching Hospitals NHS Trust Castle Hill Hospital. The company is now concentrating on the veterinary market, which represents a significantly higher emissions footprint compared to hospitals.
➡ Vortex Biosciences is focused on generating tightly scoped studies with leading researchers to highlight evidence of the technology to pharma and biotech customers.
➡ PDS Biotechnology has reported its 2023 financial results and outlined its clinical development strategy, which includes Phase 3 plans to address the growing incidence of advanced HPV+ HNSCC after FDA guidance.
➡ Ventive Limited and Q-Bot Ltd exhibited at the Futurebuild 2024 conference, where they showcased their innovative built environment solutions.

👇 Subscribe to our newsletter for more insights and updates: hxxps://lnkd.in/etxzjW6J

[loafofbread] 26/3/2024 22:17

You would think a 46000 buy would add a few pence.

[loafofbread] 20/3/2024 22:40

25K Director buy?